Fresenius CareDE0005785802FMEFME
Financials
Market Cap
$12.93B5Y beta
0.84EPS (TTM)
$1.796Free Float
199.03MP/E ratio (TTM)
24.55Revenue (TTM)
$21.22BEBITDA (TTM)
$3.93BFree Cashflow (TTM)
$2.08BPricing
Analyst Ratings
The price target is $42.91 and the stock is covered by 22 analysts.
Buy
5
Hold
12
Sell
5
Information
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.